Value of 18F-FDG PET in the detection of peritoneal carcinomatosis
- 16 June 2004
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 31 (10) , 1413-1420
- https://doi.org/10.1007/s00259-004-1577-y
Abstract
Peritoneal carcinomatosis can be difficult to diagnose using computed tomography (CT). The purpose of this study was to evaluate the role of 2-(fluorine 18) fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET) in the detection of peritoneal carcinomatosis.Keywords
This publication has 25 references indexed in Scilit:
- Positron Emission Tomography with FDG in the Detection of Peritoneal and Retroperitoneal Metastases of Ovarian CancerGynecologic and Obstetric Investigation, 2003
- Detection of Malignant Tumors: Whole-Body PET with Fluorine 18 α-Methyl Tyrosine versus FDG—Preliminary StudyRadiology, 2001
- Anatomy of SUVNuclear Medicine and Biology, 2000
- Transvaginal Versus Transrectal Ultrasonography in The Diagnosis of Peritoneal CarcinomatosisAmerican Journal of Gastroenterology, 2000
- The peritoneum, mesenteries and omenta: normal anatomy and pathological processesEuropean Radiology, 1998
- The query cornerAbdominal Radiology, 1997
- Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer.1996
- CT differentiation of tuberculous peritonitis and peritoneal carcinomatosis.American Journal of Roentgenology, 1996
- Evaluation of computed tomography in patients with peritoneal carcinomatosisCancer, 1993
- EFFICIENT STEREOSPECIFIC SYNTHESIS OF NO-CARRIER-ADDED 2-[F-18]-FLUORO-2-DEOXY-D-GLUCOSE USING AMINOPOLYETHER SUPPORTED NUCLEOPHILIC-SUBSTITUTION1986